
                                SEQUENCE LISTING

<110> Mayo Foundation for Medical Education and Research

<120> METHODS AND MATERIALS FOR GENERATING T CELLS

<130> 07039-0898WO1

<150> US 61/153,771       
<151> 2009-02-19  

<160> 33

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 15
<212> PRT
<213> Mus musculus

<400> 1
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly
 1               5                  10                  15  


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> DC3 amino acid sequence

<400> 2
Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
 1               5                  10          


<210> 3
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> invariant chain amino acid sequence

<400> 3
Leu Met Arg Lys
 1              


<210> 4
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> furin sensitive linker

<400> 4
Arg Ala Arg Arg
 1              


<210> 5
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<220> 
<221> VARIANT        
<222> 5
<223> Xaa = Epsilon amino-n-valeric

<400> 5
Leu Arg Met Lys Xaa Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp
 1               5                  10                  15      
Asn His Cys Gly
            20  


<210> 6
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 6
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Ala Arg Arg Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25                  30      


<210> 7
<211> 36
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<220> 
<221> VARIANT        
<222> 5
<223> Xaa = Epsilon-amino-n-valeric acid

<400> 7
Leu Arg Met Lys Xaa Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp
 1               5                  10                  15      
Asn His Cys Gly Arg Ala Arg Arg Phe Tyr Pro Ser Tyr His Ser Thr
            20                  25                  30          
Pro Gln Arg Pro
        35      


<210> 8
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 8
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Val
 1               5                  10                  15      
Arg Val Val Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25                  30      


<210> 9
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 9
Lys Ile Asp Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Arg Arg Arg Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25                  30      


<210> 10
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 10
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Lys Arg Arg Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25                  30      


<210> 11
<211> 33
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 11
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Ala Arg Tyr Lys Arg Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg
            20                  25                  30          
Pro
    


<210> 12
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> cleavage site

<400> 12
Arg Ala Arg Tyr Lys Arg
 1               5      


<210> 13
<211> 30
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 13
Lys Asp Ile Ser Tyr Leu Arg Phe Asn Trp Asn His Cys Gly Arg Ala
 1               5                  10                  15      
Arg Arg Phe Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25                  30  


<210> 14
<211> 28
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 14
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Ala Arg Arg Ser Tyr His Ser Thr Pro Gln Arg Pro
            20                  25              


<210> 15
<211> 25
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 15
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Ala Arg Arg Ser Thr Pro Gln Arg Pro
            20                  25  


<210> 16
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetically generated polypeptide

<400> 16
Lys Asp Ile Ser Tyr Leu Tyr Arg Phe Asn Trp Asn His Cys Gly Arg
 1               5                  10                  15      
Ala Arg Arg Gln Arg Pro
            20          


<210> 17
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> invariant chain (Ii) amino acid sequences

<400> 17
Leu Arg Met Lys Leu Pro Lys Ser
 1               5              


<210> 18
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> invariant chain (Ii) amino acid sequences

<400> 18
Leu Arg Met Lys Leu Pro Lys Ser Ala Lys Pro
 1               5                  10      


<210> 19
<211> 14
<212> PRT
<213> Artificial Sequence

<220> 
<223> invariant chain (Ii) amino acid sequences

<400> 19
Leu Arg Met Lys Leu Pro Lys Ser Ala Lys Pro Val Ser Lys
 1               5                  10                  


<210> 20
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 20
Leu Leu Thr Phe Trp Asn Pro Pro Thr Thr Ala Lys Leu Thr Ile
 1               5                  10                  15  


<210> 21
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 21
Tyr Leu Trp Trp Val Asn Asn Gln Ser Leu Pro Val Ser Pro Arg
 1               5                  10                  15  


<210> 22
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 22
Arg Thr Thr Val Lys Thr Ile Thr Val Ser Ala Glu Leu Pro Lys
 1               5                  10                  15  


<210> 23
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 23
Tyr Ala Cys Phe Val Ser Asn Leu Ala Thr Gly Arg Asn Asn Ser
 1               5                  10                  15  


<210> 24
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 24
Asn Leu Glu Leu Thr Tyr Leu Pro Thr Asn Ala Ser Leu Ser Phe
 1               5                  10                  15  


<210> 25
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 25
His Asn Gln Val Arg Gln Val Pro Leu Gln Arg Leu Arg Ile Val
 1               5                  10                  15  


<210> 26
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 26
Leu Ser Val Phe Gln Asn Leu Gln Val Ile Arg Gly Arg Ile Leu
 1               5                  10                  15  


<210> 27
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 27
Pro Ile Lys Trp Met Ala Leu Glu Ser Ile Leu Arg Arg Arg Phe
 1               5                  10                  15  


<210> 28
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 28
Leu Leu Pro Leu Leu Pro Leu Leu Leu Leu Leu Leu Gly Ala Ser
 1               5                  10                  15  


<210> 29
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 29
Pro Leu Leu Leu Leu Leu Leu Gly Ala Ser Gly Gly Gly Gly Gly
 1               5                  10                  15  


<210> 30
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 30
Glu Arg Gly Pro Leu Glu His Leu Tyr Ser Leu His Ile Pro Asn
 1               5                  10                  15  


<210> 31
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> MHC class II epitopes sequences

<400> 31
Thr Gly Lys Leu Ile Gln Gly Ala Pro Thr Ile Arg Gly Asp Pro
 1               5                  10                  15  


<210> 32
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Epsilon-amino-n-valeric acid sequences

<400> 32
Gly Gly Ser Gly Gly Ser
 1               5      


<210> 33
<211> 15
<212> PRT
<213> Homo sapiens

<400> 33
Gln Cys Arg Pro Trp Arg Lys Asn Ala Cys Cys Ser Thr Asn Thr
 1               5                  10                  15  

